Pharming Group (Pharming Group) COGS-to-Revenue : 0.09 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Pharming Group COGS-to-Revenue?

Pharming Group's Cost of Goods Sold for the three months ended in Dec. 2023 was $7.1 Mil. Its Revenue for the three months ended in Dec. 2023 was $81.2 Mil.

Pharming Group's COGS to Revenue for the three months ended in Dec. 2023 was 0.09.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pharming Group's Gross Margin % for the three months ended in Dec. 2023 was 91.24%.

Pharming Group COGS-to-Revenue Historical Data

The historical data trend for Pharming Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group COGS-to-Revenue Chart

Pharming Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.13

0.11

0.09

0.10

Pharming Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.11	0.10	0.10	0.12	0.09

Pharming Group COGS-to-Revenue Calculation

Pharming Group's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	25.212	/	245.316
	=	0.10

Pharming Group's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.118	/	81.217
	=	0.09

Pharming Group (NAS:PHAR) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pharming Group's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	7.118 / 81.217
	=	91.24 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Pharming Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharming Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group (Pharming Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (NAS:PHAR) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

PHGUF:USA PHARM:Netherlands PHARMa:UK 0QCO:UK PHGN:Germany

Address

Darwinweg 24, Leiden, ZH, NLD, 2333 CR

Website

https://www.pharming.com

Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.